Compound information
- Natural Products
- ZC11061
- Molecular Formula
- C8H12N2O2
- Molecular Weight
- 168.089877624 g/mol
- Structure
-
- IUPAC Name
- 1-(4-aminobutyl)pyrrole-2,5-dione
- InChI
- InChI=1S/C8H12N2O2/c9-5-1-2-6-10-7(11)3-4-8(10)12/h3-4H,1-2,5-6,9H2
- InChI Key
- PBDFRUDGHBFXII-UHFFFAOYSA-N
- SMILES
- NCCCCN1C(=O)C=CC1=O
- Source
- ZINC000095630318
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 12 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.4 Å2 | LogP | -0.631 |
LogS | -0.272 | LogD | -0.854 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.029 | Pgp substrate | 0.712 |
HIA | 0.741 | F20 % | 0.989 |
F30 % | 0.378 | Caco-2 | -4.803 |
MDCK | -5.481 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.869 | PPB | 34.716 |
VD | 0.851 | Fu | 0.2 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.091 | CYP1A2 substrate | 0.608 |
CYP2A6 substrate | 0.578 | CYP2B6 substrate | 0.529 |
CYP2C19 inhibitor | 0.04 | CYP2C19 substrate | 0.447 |
CYP2C8 substrate | 0.518 | CYP2C9 inhibitor | 0.028 |
CYP2C9 substrate | 0.013 | CYP2D6 inhibitor | 0.012 |
CYP2D6 substrate | 0.243 | CYP2E1 substrate | 0.753 |
CYP3A4 inhibitor | 0.004 | CYP3A4 substrate | 0.176 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.839 | CL | 5.387 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.008 | Hepatotoxicity | 0.106 |
Mutagenicity | 0.014 | Rat Oral Acute Toxicity | 0.386 |
FDAMDD | 0.245 | Skin Sensitization | 0.976 |
Carcinogenicity | 0.208 | Eye Corrosion | 0.96 |
Eye Irritation | 0.959 | Respiratory Toxicity | 0.121 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.105 | IGC50 | 2.558 |
LC50FM | 2.189 | LC50DM | 3.64 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.1 | NR-AR-LBD | 0.262 |
NR-AhR | 0.004 | NR-Aromatase | 0.111 |
NR-ER | 0.216 | NR-ER-LBD | 0.356 |
NR-PPAR-gamma | 0.681 | SR-ARE | 0.87 |
SR-ATAD5 | 0.511 | SR-HSE | 0.877 |
SR-MMP | 0.024 | SR-p53 | 0.716 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.